Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.

Hairy enhancer of split 1 (Hes1) is a basic helix-loop-helix transcriptional repressor that affects differentiation and often helps maintain cells in an immature state in various tissues. Here we show that retroviral expression of Hes1 immortalizes common myeloid progenitors (CMPs) and granulocyte-macrophage progenitors (GMPs) in the presence of interleukin-3, conferring permanent replating capability on these cells. Whereas these cells did not develop myeloproliferative neoplasms when intravenously administered to irradiated mice, the combination of Hes1 and BCR-ABL in CMPs and GMPs caused acute leukemia resembling blast crisis of chronic myelogenous leukemia (CML), resulting in rapid death of the recipient mice. On the other hand, BCR-ABL alone caused CML-like disease when expressed in c-Kit-positive, Sca-1-positive, and lineage-negative hematopoietic stem cells (KSLs), but not committed progenitors CMPs or GMPs, as previously reported. Leukemic cells derived from Hes1 and BCR-ABL-expressing CMPs and GMPs were more immature than those derived from BCR-ABL-expressing KSLs. Intriguingly, Hes1 was highly expressed in 8 of 20 patients with CML in blast crisis, but not in the chronic phase, and dominant negative Hes1 retarded the growth of some CML cell lines expressing Hes1. These results suggest that Hes1 is a key molecule in blast crisis transition in CML.

[1]  M. Seto,et al.  Gain‐of‐function mutations and copy number increases of Notch2 in diffuse large B‐cell lymphoma , 2009, Cancer science.

[2]  Daniel G Tenen,et al.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  James M. Roberts,et al.  Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1 , 2008, Science.

[4]  S. Ogawa,et al.  Coordinated regulation of transcription factors through Notch2 is an important mediator of mast cell fate , 2008, Proceedings of the National Academy of Sciences.

[5]  Heidi Dvinge,et al.  Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. , 2008, Cancer cell.

[6]  K. McCue,et al.  Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling , 2008, Oncogene.

[7]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[8]  L. Fu,et al.  NOTCH1 mutations are rare in acute myeloid leukemia , 2006, Leukemia & lymphoma.

[9]  Y. Hayashi,et al.  Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children , 2005, Leukemia.

[10]  M. Fey,et al.  The Notch pathway in ovarian carcinomas and adenomas , 2005, British Journal of Cancer.

[11]  K. Akashi,et al.  Identification of eosinophil lineage–committed progenitors in the murine bone marrow , 2005, The Journal of experimental medicine.

[12]  Hideaki Nakajima,et al.  Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. , 2005, The Journal of clinical investigation.

[13]  T. Lister,et al.  Mutation of CEBPA in familial acute myeloid leukemia. , 2004, The New England journal of medicine.

[14]  Pu Zhang,et al.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. , 2004, Immunity.

[15]  K. Akashi,et al.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. , 2004, Cancer cell.

[16]  Arie Perry,et al.  Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.

[17]  Joel I. Pritchard,et al.  The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas , 2004, Cancer Research.

[18]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[19]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[20]  M. Nakafuku,et al.  Hes binding to STAT3 mediates crosstalk between Notch and JAK–STAT signalling , 2004, Nature Cell Biology.

[21]  C. Nerlov C/EBPα mutations in acute myeloid leukaemias , 2004, Nature Reviews Cancer.

[22]  Freddy Radtke,et al.  Notch regulation of lymphocyte development and function , 2004, Nature Immunology.

[23]  I. Weissman,et al.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. , 2003, Genes & development.

[24]  T. Kitamura,et al.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.

[25]  I. Weissman,et al.  Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Kageyama,et al.  HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. , 2003, Blood.

[27]  J. Aster,et al.  Notch Signaling in Cancer , 2002, Cancer biology & therapy.

[28]  W. El-Deiry Transactivation of Repair Genes by BRCA1 , 2002, Cancer biology & therapy.

[29]  C. Lavau,et al.  Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations , 2002, Oncogene.

[30]  J. Aster,et al.  An Invitation to T and More Notch Signaling in Lymphopoiesis , 2002, Cell.

[31]  Carl W. Miller,et al.  Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. , 2002, Blood.

[32]  T. Yamagata,et al.  Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression. , 2001, Blood.

[33]  T. Kitamura,et al.  Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.

[34]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[35]  H. Nakauchi,et al.  A Role for Pref-1 and HES-1 in Thymocyte Development , 2000, The Journal of Immunology.

[36]  K. Tomita,et al.  The bHLH gene Hes1 is essential for expansion of early T cell precursors. , 1999, Genes & development.

[37]  H. Macdonald,et al.  Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.

[38]  A. Israël,et al.  Delta-1 Activation of Notch-1 Signaling Results inHES-1 Transactivation , 1998, Molecular and Cellular Biology.

[39]  R. Kageyama,et al.  Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system. , 1997, Current opinion in genetics & development.

[40]  F. Ferrara,et al.  JURL-MK1 (c-kithigh/CD30−/CD40−) and JURL-MK2 (c-kitlow/CD30+/CD40+) cell lines: ‘two-sided’ model for investigating leukemic megakaryocytopoiesis , 1997, Leukemia.

[41]  Christel Brou,et al.  Signalling downstream of activated mammalian Notch , 1995, Nature.

[42]  Y. Yazaki,et al.  Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. , 1995, Blood.

[43]  R. Sasaki,et al.  Establishment of an erythroid cell line (JK‐1) that spontaneously differentiates to red cells , 1990, Cancer.

[44]  David J. Anderson,et al.  Two rat homologues of Drosophila achaete-scute specifically expressed in neuronal precursors , 1990, Nature.

[45]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[46]  C. Nerlov C/EBPalpha mutations in acute myeloid leukaemias. , 2004, Nature reviews. Cancer.

[47]  M. Masu,et al.  Conversion of biliary system to pancreatic tissue in Hes1-deficient mice , 2004, Nature Genetics.

[48]  A. Gotoh,et al.  Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. , 1995, Experimental hematology.

[49]  I. Miyoshi,et al.  Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. , 1983, International journal of cell cloning.

[50]  I. Bernstein,et al.  Hedgehog-Induced Medulloblastomas Critical for the Growth and Survival of Sonic The SmoA 1 Mouse Model Reveals That Notch Signaling Is Updated , 2022 .